Skip to Content

Deferasirox Mylan 360 mg film-coated tablets

Licence status
Authorised: 26/09/2019
Active substances
Deferasirox
Dosage Form
Film-coated tablet
Licence number
EU/1/19/1386/011-016
Licence holder
Mylan Pharmaceuticals Limited

Licence information

ATC code
V03AC Iron chelating agents, V03AC03 deferasirox
Route of supply
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
26/09/2019

Stay updated: document advice

The information and documents on this page are subject to frequent updates. We recommend you do not retain saved or printed versions of them. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie